Acromegaly: Debio 4126 Treatment Study

We are testing a new formulation of Debio 4126 in patients with acromegaly who have been treated with other medications. The study aims to see if it helps maintain normal hormone levels and evaluates its safety compared to a placebo.

1-2 years >20 visits Confirmation phase (III)Post-Trial Drug Access Cost Reimbursement Investigational Medicines Oral InjectionEndocrinology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Octreotide

Octreotide is a medicine that reduces excess hormone effects, used for conditions like acromegaly and certain hormone-secreting tumors.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Lanreotide

Lanreotide is a somatostatin analogue used to treat acromegaly and control symptoms of neuroendocrine tumors.

Octreotide

Octreotide is a synthetic somatostatin-like substance that reduces excessive hormone release from certain tumors and helps control related symptoms.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Debio 4126

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Octrayne

Octreo

Octreotid Bendalis

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Medical University Of Graz

Division of Endocrinology and Diabetology

Graz, Austria

Medical University Of Vienna

Department of Medicine III (Division of Endocrinology and Metabolism)

Vienna, Austria

Universitair Ziekenhuis Gent

Endocrinology

Ledeberg, Belgium

Sponsor: Debiopharm International S.A.

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.